ConductScience.org, home

Gene · 2892

GRIA3: glutamate ionotropic receptor AMPA type subunit 3

12 sourcesgene-search-2026-11-11-0.2.0

Download JSON
Cite this record

ConductScience Library. GRIA3: glutamate ionotropic receptor AMPA type subunit 3. Genes, record 2892. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/2892

On this page

Gene

Symbol
GRIA3
HGNC
Name
glutamate ionotropic receptor AMPA type subunit 3
HGNC
NCBI Gene ID
2892
NCBI Gene
HGNC ID
HGNC:4573
HGNC
Ensembl
ENSG00000125675
NCBI Gene
Aliases
GLUR-C, GLUR-K3, GLUR3, GLURC, GluA3, GluR-3, GluR-C, GluR-K3, MRX94, MRXSW, iGluR3
NCBI Gene
Type
protein-coding
NCBI Gene

Proteins1

Reviewed human proteins whose Swiss-Prot entry states the gene.

UniProt entryProteinLengthStructuresGene stated in
P42263Glutamate receptor 38940Ensembl, GeneID, HGNC

Source UniProt

Patents49

Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.

PublicationPublishedSEQ ID NOProteinSource
JP 2026004568 A2026-01-1447702P42263Espacenet
JP 2026004568 A2026-01-1447704P42263Espacenet
EP 4650780 A22025-11-1916439P42263Espacenet
EP 4641201 A22025-10-2920234P42263Espacenet
JP 2025147176 A2025-10-066209P42263Espacenet
JP 2025147176 A2025-10-066210P42263Espacenet
JP 2025529142 A2025-09-041865P42263Espacenet
JP 2025529142 A2025-09-046544P42263Espacenet
US 12371689 B22025-07-291865P42263Espacenet
US 12371689 B22025-07-296544P42263Espacenet

1 to 10 of 49

See all 49 patents

Drugs15

Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.

DrugChEMBL IDMechanismActionSource
BECAMPANELCHEMBL3989682Glutamate receptor ionotropic AMPA antagonistANTAGONISTChEMBL
CX1739CHEMBL3707399Glutamate receptor ionotropic AMPA positive allosteric modulatorPOSITIVE ALLOSTERIC MODULATORChEMBL
DASOLAMPANELCHEMBL2103869Glutamate receptor ionotropic AMPA antagonistANTAGONISTChEMBL
FARAMPATORCHEMBL1276138Glutamate receptor ionotropic AMPA positive allosteric modulatorPOSITIVE ALLOSTERIC MODULATORChEMBL
IRAMPANELCHEMBL29741Glutamate receptor ionotropic AMPA antagonistANTAGONISTChEMBL
MIBAMPATORCHEMBL1277001Glutamate receptor ionotropic AMPA positive allosteric modulatorPOSITIVE ALLOSTERIC MODULATORChEMBL
MK-8777CHEMBL3707401Glutamate receptor ionotropic AMPA positive allosteric modulatorPOSITIVE ALLOSTERIC MODULATORChEMBL
OSAVAMPATORCHEMBL4594403Glutamate receptor ionotropic AMPA positive allosteric modulatorPOSITIVE ALLOSTERIC MODULATORChEMBL
PERAMPANELCHEMBL1214124Glutamate receptor ionotropic AMPA antagonistANTAGONISTChEMBL
PESAMPATORCHEMBL5095022Glutamate receptor ionotropic AMPA positive allosteric modulatorPOSITIVE ALLOSTERIC MODULATORChEMBL

1 to 10 of 15

See all 15 drugs

Trials231

Trials of those drugs. A trial joins the gene only through a drug that acts on it.

TrialDrugPhaseResults first postedSource
NCT07588750TOPIRAMATEClinicalTrials.gov
NCT07384624TOPIRAMATEPHASE1/PHASE2ClinicalTrials.gov
NCT07284069PERAMPANELEARLY_PHASE1ClinicalTrials.gov
NCT06347497TOPIRAMATEPHASE3ClinicalTrials.gov
NCT06299891TOPIRAMATEPHASE2ClinicalTrials.gov
NCT06248931TOPIRAMATEPHASE3ClinicalTrials.gov
NCT06243692TOPIRAMATEPHASE3ClinicalTrials.gov
NCT05958160TOPIRAMATEPHASE2/PHASE3ClinicalTrials.gov
NCT05915013PERAMPANELPHASE1ClinicalTrials.gov
NCT05786066PERAMPANELPHASE2ClinicalTrials.gov

1 to 10 of 231

See all 231 trials

NIH grants1,297

NIH grants whose papers are about the gene, through NIH's grant-paper links.

GrantTitleGRIA3 papersNewest fiscal year
ZIAMH002857Glutamatergic Modulators for Rapid and Sustained Antidepressant Effect62025
R01DC013048Mechanisms of hypersensitivity to sound-induced cochlear damage52025
ZIAMH002844Genetic Determinants of Antidepressant Response42025
P30AG066512Alzheimer's Disease Research Center - Administrative Supplement 202532025
P30ES023513UC Davis Environmental Health Sciences Core Center32025
P30EY004068Core Grant for Vision Research32025
P51OD010425Washington National Primate Research Center32025
R01AG070255Mechanisms of Synaptic Protection in Cognitive Resilence to Alzheimer's Disease Neuropathology32025
R01HD082373NMDAR Mutations & Neurodevelopmental Disorder: from Mechanism to Targeted Therapy32025
R28AA012725Brain Tissue Resource Center for Alcohol Research32025

1 to 10 of 1,297Source NIH's project files

See all 1,297 nih grants

Papers1,596

Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.

TitleJournalYearPMIDFound bySource
A seven-gene signature associated with inner mitochondrial membrane protein-defined molecular subtypes for prognostic stratification in gastric cancer.Pathol Res Pract202642805121PubTator, text miningPubMed
Epilepsy as a Disorder of Neuroimmune Metabolism: The Kynurenine Pathway as a Link Between Cognitive and Psychiatric Dysfunction.Biomolecules202642793132PubTator, text miningPubMed
Oncohistone inhibition reshapes tumor-microenvironment communication in Diffuse Midline Glioma (DMG).bioRxiv202642779592PubTator, text miningPubMed
GRIA3 Duplication at Xq25 in a Young Adult Male With Profound Intellectual Disability and Morbid Obesity: A Case Report.Case Rep Genet202642774871PubTator, text miningPubMed
Reclassification of the GRIA3 splice-site variant in an X-linked family with intellectual disability and psychiatric symptoms.Front Genet202642666715PubTator, text miningPubMed
AMPAR Subunit Gene Expression Marks a Synaptic Transcriptional State in Lower-Grade Glioma.Brain Sci202642651084PubTator, text miningPubMed
GRIA3: proposal for a neuroimmune role linking infection, stress, chronic disorders and the activity of kynurenic acid.Front Cell Neurosci202642638935PubTator, text miningPubMed
α/β-Hydrolase domain-containing 6 (ABHD6) accelerates the desensitization and deactivation of TARP γ-2-containing AMPA receptors.Elife202642610232PubTator, text miningPubMed
Subgroup-Specific Associations of GRIA Genes Encoding AMPA Glutamate Receptor Subunits with Patient Survival in Medulloblastoma.Neuromolecular Med202642277445PubTator, text miningPubMed
Autoimmune mechanisms in drug-resistant focal epilepsy: Pathophysiology, biomarkers, and therapeutic implications.Adv Clin Exp Med202642046327PubTator, text miningPubMed

1 to 10 of 1,596

See all 1,596 papers

Sources 12

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this gene from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/genes/v1/2892

GET https://conductscience.org/api/genes/v1/2892/patents?page=2